Document is current

Article History

Received: 24 June 2022

Accepted: 12 August 2022

First Online: 3 October 2022

Declarations

:

: The study was approved by the local Ethics Committee of the Christian Albrecht University of Kiel (AZ: D596/21). Informed patient consent was not necessary for this work. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.

: Not applicable.

: CJ declares that he has no competing interests. KEZ has received research support from Strathmann. She reports speaker's honoraria from Bayer Vital GmbH, BIAL, AbbVie Allergan and Merz outside the submitted work. She has served as a consultant and received fees from Merz, Ipsen, Alexion and the German Federal Institute for Drugs and Medical Devices (BfArM). AKH has received financial research support by the DFG (SFB 1261) and lecture fees from Medtronic. KW serves as a consultant for BIAL and is a member of advisory boards of Biogen and Stadapharm. He receives royalties form Thieme publishers and Elsevier. GD has served as a consultant for Boston Scientific, Aleva, Cavion and Functional Neuromodulation. He has received lecture fees from Boston Scientific and royalties from Thieme publishers. He is a government employee and receives funding for his research through his institution from the German Research Council, the German Ministery of Education and Research and Medtronic. SP has received lecture fees from Medtronic, Insightec and Boston Scientific, travel grants from Desitin and AbbVie, educational grants from AbbVie and Boston Scientific.